Showing results (41-50 of 288) with videos related to
Sort By:
Pageof 29
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 10, 2006
[Angioma serpiginosum following the lines of Blaschko--an effective treatment with the IPL technology]Nina Poenitz, Wolfgang Koenen, Jochen Utikal, et al.Experimental Dermatology|January 7, 2004
Molecular genetics of Xeroderma pigmentosum variantAlexei Gratchev, Pamela Strein, Jochen Utikal, et al.Advances in Medical Sciences|January 18, 2015
New therapeutic options for advanced non-resectable malignant melanomaSimone Stadler, Kasia Weina, Christoffer Gebhardt, et al.Cancer Immunology, Immunotherapy : CII|October 11, 2018
Opposing roles of eosinophils in cancerSonja C S Simon, Jochen Utikal, Viktor UmanskyJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2014
Myeloid-derived suppressor cells in malignant melanomaViktor Umansky, Alexandra Sevko, Christoffer Gebhardt, et al.Vaccines|November 10, 2016
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionViktor Umansky, Carolin Blattner, Christoffer Gebhardt, et al.Methods in Cell Biology|January 31, 2026
In vitro generation of human CD14<sup>+</sup> MDSC-like cells from normal human monocytesFeyza Gul Ozbay Kurt, Jochen Utikal, Viktor UmanskyCancers|December 17, 2020
HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in MelanomaLaura Hüser, Marianthi-Maria Kokkaleniou, Karol Granados, et al.International Journal of Cancer|November 5, 2016
D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progressAnna Desch, Christoffer Gebhardt, Jochen Utikal, et al.Cancer Immunology, Immunotherapy : CII|April 24, 2014
Extracellular adenosine metabolism in immune cells in melanomaViktor Umansky, Ivan Shevchenko, Alexandr V Bazhin, et al.Pageof 29